Available ebook formats: epub
Todd Eldredge PhD, MPH, MBA.
Todd Eldredge is the Founder and Chief Executive Officer of CardioRisk Laboratories, an international heart attack, and stroke prevention company. Eldredge co-founded the WellnessVIP (Vascular Improvement Program) (WellnessVIP, Inc.; www.wellnessvip.org) which integrates phenotypical, genotypical, and physical diagnostic testing to diagnose at-risk patient, optimize their care, and monitor the efficacy of treatment in patients with increased cardiovascular risk.
Prior to CardioRisk and WellnessVIP, Eldredge was a founder and/or senior executive of several bio and technical companies with roots in quality, technology, and biologicals whose combined revenues exceeded $100MM in annual revenue. He helped to raise over $180MM in venture capital for these companies and he continues to consult for several technology based enterprises. Eldredge is a published best selling author and researcher and is involved in many CIMT-related research projects. Todd has spent many years developing performance-based testing protocols to demonstrate operator-dependent coefficients of variability and testing reproducibility. He spent 10 years at what is now Sanofi-Pasteur where he ran a Pediatric Vaccine Business Unit. Eldredge has a BSBA, MBA, and MPH degrees and a PhD in cardiovascular epidemiology.